Francesca Lacaria

Bachelor's degree in Pharmacy from the University of Pavia, with an experimental thesis in anatomy titled: "Observations on the microvascularization of salivary glands and the endocrine pancreas."

Specialization in Hospital Pharmacy at the University of Modena and Reggio Emilia, with a thesis titled: "Lenalidomide: critical elements for assessing the risk/benefit profile in relation to its inclusion in a therapeutic formulary." Since 2019, she has been a radiopharmacist and the Quality Assurance and Quality Control Manager at the Radiopharmaceutical Chemistry Laboratory (RACHEL) within the Nuclear Medicine Unit - Oncological and Advanced Technologies Department. She is also a member of the staff for Phase 1 clinical trials.